Eisai News
Most Popular Eisai Story
TorreyPines sells Alzheimer's rights to Eisai
TorreyPines Therapeutics announced yesterday that it has sold its Alzheimer's disease genetics research program to Eisai for an undisclosed up-front cash payment. The Alzheimer's program involved the... Read more...
Latest Headlines
- November 10, 2008
- July 28, 2008
- April 11, 2008
- March 6, 2008
- February 14, 2008
- February 1, 2008
- December 10, 2007
- September 5, 2007
- November 16, 2006
- October 15, 2006
- September 13, 2006
- September 7, 2006
- July 11, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
